Back to top

Aldeyra (ALDX) Resubmits Reproxalap NDA to FDA

Aldeyra (ALDX) Resubmits Reproxalap NDA to FDA

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Aldeyra Therapeutics, Inc. (ALDX)